7-hydroxy-2-n,n-dipropylaminotetralin and aripiprazole

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with aripiprazole in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forbes, RA; Kikuchi, T; McQuade, RD; Tadori, Y1
Hoenicka, J; Jiménez-Arriero, MÁ; Martín-Palanco, NG; Palomo, T; Ponce, G; Quiñones-Lombraña, A; Rubio-Solsona, E1

Other Studies

2 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and aripiprazole

ArticleYear
Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.
    European journal of pharmacology, 2008, Nov-12, Volume: 597, Issue:1-3

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Mutation; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D3; Tetrahydronaphthalenes; Transfection

2008
The Addiction-Related Gene Ankk1 is Oppositely Regulated by D1R- and D2R-Like Dopamine Receptors.
    Neurotoxicity research, 2016, Volume: 29, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Aripiprazole; Brain; Down-Regulation; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Tetrahydronaphthalenes; Up-Regulation

2016